Actress Shilpa Shetty has been appointed the brand ambassador for SRL Diagnostics. The diagnostics chain has rolled out a new preventive customized health check platform under...
Granules India, a ₹1690 crore plus pharma giant, has posted strong growth in consolidated net profit of 40.8 percent during the first quarter ended June 2018 basically...
The latest major innovation for the product is the introduction of these two Eppendorf Conical Tube versions. The Protein LoBind Conical Tubes minimize the risk of...
Zydus Cadila has received the final approval from the USFDA to market Acetylcysteine Injection (US RLD – Acetadote Injection), 6 g/30 mL (200 mg/mL). It is...
Symple Wellness Platform (SWP), a Singapore based Health Tech start-up, announced that it has acquired Pune-based AllizHealth (AIH), a wellness and health analytics platform for an...
Dr. Reddy’s Laboratories Ltd. announced the launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg, an over-the-counter (OTC) therapeutic equivalent generic version of Nexium 24HR Capsules...
Zydus Cadila has received the final approval from the USFDA to market Spironolactone Tablets USP (US RLD – Aldactone Tablets) in strengths of 25 mg, 50...
A unit of Chinese conglomerate Fosun International Ltd is mulling an initial public offering (IPO) of Hyderabad-based Gland Pharma, Bloomberg reported. The share sale could raise...
Jubilant Life Sciences has announced that its wholly own subsidiary Jubilant Pharma, through one of its units Jubilant DraxImage Inc. Montreal, Canada, has initiated OPTIMUM trial...
Pharma major Lupin announced that it has received tentative approval for its Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg from the...
Zydus Cadila has received the final approval from the USFDA to market Piroxicam Capsules USP (US RLD – Feldene Capsules) in strengths of 10 mg and...
Amazon.com Inc is in early talks to invest in Indian pharmacy chain MedPlus, Indian news website FactorDaily reported, citing sources. MedPlus Health Services runs over 1500...
Cipla is taking the acquisition and product in-licensing route to consolidate its business in Africa, the company’s second-largest market after India. Africa contributed 22 percent to...
Sun Pharmaceutical Industries Ltd. announced that it has received approval from the US Food and Drug Administration (USFDA) for INFUGEM (gemcitabine in 0.9 percent sodium chloride...
Zydus Cadila announced that it has received four consecutive final approvals from the USFDA to market Olanzapine Tablets USP, Glipizide Extended-Release Tablets, Voriconazole for Injection and...
Copyright © 2024 Medical Buyer